Hepatitis C Virus Elimination Programs in Louisiana and Washington: Importance of Screening and Surveillance Systems
Authors:
- Andrew H. TalalATAndrew H. Talal
- Arpan DhariaADArpan Dharia
- Shashi N. KapadiaSKShashi N. Kapadia
- Gia L. TysonGTGia L. Tyson
- Susan Mba BirchSBSusan Mba Birch
- Judy Zerzan-ThulJZJudy Zerzan-Thul
- Donna SullivanDSDonna Sullivan
- Elizabeth Msn BrittonEBElizabeth Msn Britton
- Elaine WethingtonEWElaine Wethington
- Christopher J. Md GonzalezCGChristopher J. Md Gonzalez
- Mary Bs FlissMFMary Bs Fliss
- Brandon MizrochBMBrandon Mizroch
Open Access
- 18 August 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 30 (2) , 208-212
Abstract
The US government has established a national goal of hepatitis C virus (HCV) elimination by 2030. To date, most HCV elimination planning and activity have been at the state level. Fifteen states presently have publicly available HCV elimination plans. In 2019, Louisiana and Washington were the first states to initiate 5-year funded HCV elimination programs. These states differ on motivation for pursuing HCV elimination and ranking on several indicators. Simultaneously, however, they have emphasized several similar elimination components including HCV screening promotion through public awareness, screening expansion, surveillance enhancement (including electronic reporting and task force development), and harm reduction. The 13 other states with published elimination plans have proposed the majority of the elements identified by Louisiana and Washington, but several have notable gaps. Louisiana's and Washington's comprehensive plans, funding approaches, and programs provide a useful framework that can move states and the nation toward HCV elimination.Keywords
This publication has 6 references indexed in Scilit:
- A National Hepatitis C Elimination Program in the United StatesJAMA, 2023
- Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United StatesJournal of Health Politics, Policy and Law, 2022
- Vital Signs:Newly Reported Acute and Chronic Hepatitis C Cases ― United States, 2009–2018MMWR. Morbidity and Mortality Weekly Report, 2020
- Universal Screening for Hepatitis C Virus InfectionJAMA, 2020
- Design of an Enhanced Public Health Surveillance System for Hepatitis C Virus Elimination in King County, WashingtonPublic Health Reports®, 2019
- Estimating Acute Viral Hepatitis Infections From Nationally Reported CasesAmerican Journal of Public Health, 2014